Ingram JR - Search Results

1

Feasibility of daily pain measurement using text messages in hidradenitis suppurativa clinical trials; data from the THESEUS study.

Hasan SB, Bates J, Cannings-John R, Collier F, Evans J, Gibbons A, Harris C, Howells L, Hood K, Howes R, Leighton P, Riaz M, Rodrigues J, Stanton H, Thomas KS, Thomas-Jones E, Ingram JR. Hasan SB, et al. Among authors: ingram jr. Br J Dermatol. 2024 Apr 17;190(5):775-777. doi: 10.1093/bjd/ljae057. Br J Dermatol. 2024. PMID: 38365908 No abstract available.

2

The Hidradenitis Suppurativa Priority Setting Partnership.

Ingram JR, Abbott R, Ghazavi M, Alexandroff AB, McPhee M, Burton T, Clarke T. Ingram JR, et al. Br J Dermatol. 2014 Dec;171(6):1422-7. doi: 10.1111/bjd.13163. Epub 2014 Oct 30. Br J Dermatol. 2014. PMID: 24903313

3

Hidradenitis suppurativa outcome measures and treatment goals.

Ingram JR. Ingram JR. Br J Dermatol. 2014 Dec;171(6):1293-4. doi: 10.1111/bjd.13396. Br J Dermatol. 2014. PMID: 25523257 No abstract available.

4

Validation of the global resource of eczema trials (GREAT database).

Nankervis H, Devine A, Williams HC, Ingram JR, Doney E, Delamere F, Smith S, Thomas KS. Nankervis H, et al. Among authors: ingram jr. BMC Dermatol. 2015 Mar 14;15:4. doi: 10.1186/s12895-015-0024-z. BMC Dermatol. 2015. PMID: 25887502 Free PMC article.

5

Management of hidradenitis suppurativa: a U.K. survey of current practice.

Ingram JR, McPhee M. Ingram JR, et al. Br J Dermatol. 2015 Oct;173(4):1070-2. doi: 10.1111/bjd.13866. Epub 2015 Aug 22. Br J Dermatol. 2015. PMID: 25913663 No abstract available.

6

Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality.

Ingram JR, Woo PN, Chua SL, Ormerod AD, Desai N, Kai AC, Hood K, Burton T, Kerdel F, Garner SE, Piguet V. Ingram JR, et al. Br J Dermatol. 2016 May;174(5):970-8. doi: 10.1111/bjd.14418. Epub 2016 Mar 30. Br J Dermatol. 2016. PMID: 26801356 Free PMC article. Review.

7

Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the process.

Ingram JR, Hadjieconomou S, Piguet V. Ingram JR, et al. Br J Dermatol. 2016 Aug;175(2):263-72. doi: 10.1111/bjd.14475. Epub 2016 May 2. Br J Dermatol. 2016. PMID: 26873867 Review.

8

Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study.

Thomas KS, Ormerod AD, Craig FE, Greenlaw N, Norrie J, Mitchell E, Mason JM, Johnston GA, Wahie S, Williams HC; UK Dermatology Clinical Trials Network's STOP GAP Team. Thomas KS, et al. J Am Acad Dermatol. 2016 Nov;75(5):940-949. doi: 10.1016/j.jaad.2016.06.016. Epub 2016 Aug 5. J Am Acad Dermatol. 2016. PMID: 27502313

9

Adalimumab for Treating Moderate-to-Severe Hidradenitis Suppurativa: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Tappenden P, Carroll C, Stevens JW, Rawdin A, Grimm S, Clowes M, Kaltenthaler E, Ingram JR, Collier F, Ghazavi M. Tappenden P, et al. Among authors: ingram jr. Pharmacoeconomics. 2017 Aug;35(8):805-815. doi: 10.1007/s40273-017-0488-2. Pharmacoeconomics. 2017. PMID: 28176188 Free article. Review.

10

NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?

Ingram JR, Burton T. Ingram JR, et al. Br J Dermatol. 2017 Feb;176(2):281-282. doi: 10.1111/bjd.15255. Br J Dermatol. 2017. PMID: 28244073 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

423 results

Search Page